Roche Products Limited

Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW
Telephone: +44 (0)1707 366 000
Fax: +44 (0)1707 338 297
WWW: http://www.rocheuk.com
Medical Information Direct Line: +44 (0)800 328 1629
Medical Information e-mail: medinfo.uk@roche.com
Customer Care direct line: +44 (0)800 731 5711
Medical Information Fax: +44 (0)1707 384555

Patient Information Leaflet last updated on the eMC: 14/06/2011
PIL Anexate 500 micrograms/5ml Solution for Injection or Infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 14/06/2011 and displayed until Current
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 25/11/2010 and displayed until 14/06/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 12/11/2010 and displayed until 25/11/2010
Reasons for adding or updating:
  • Change to date of revision
Updated on 28/09/2010 and displayed until 12/11/2010
Reasons for adding or updating:
  • Change to storage instructions
  • Change to warnings or special precautions for use
Updated on 01/12/2008 and displayed until 28/09/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 06/05/2008 and displayed until 01/12/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 26/03/2008 and displayed until 06/05/2008
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 08/01/2007 and displayed until 26/03/2008
Reasons for adding or updating:
  • Change to Further Information section
Updated on 29/11/2005 and displayed until 08/01/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 25/07/2005 and displayed until 29/11/2005
Reasons for adding or updating:
  • Change of trade or generic name
  • Change of contra-indications
  • Change to side-effects
  • Change to storage instructions
  • Change to date of revision
Updated on 16/10/2001 and displayed until 25/07/2005
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   flumazenil